by Microlabs_Admin | Sep 25, 2020 | news
BASKING RIDGE, N.J., Sept. 25, 2020 /PRNewswire/ — Micro Labs USA Inc. announces its presence in the US Ophthalmic market of $8.5 billion (source: IQVIA MAT July 2020), by launching two products – Dorzolamide 2% and Dorzolamide-Timolol 22.3-6.8 mg/mL Micro...
by Microlabs_Admin | May 13, 2020 | news
BASKING RIDGE, N.J. and HAUPPAGUE, N.Y., May 13, 2020 /PRNewswire/ — Micro Labs USA, Inc. and Saptalis Pharmaceuticals, LLC. are strengthening their association with the launch of Metformin Oral Solution in the US market. Metformin Oral Solution is indicated as...
by Microlabs_Admin | Jan 24, 2020 | news
A new generics partnership is bringing oral liquid and topical products to the market. Micro Labs USA and Saptalis Pharmaceuticals have formed a strategic collaboration to launch single-source and multisource generics in the United States, as well as launched the...
by Microlabs_Admin | May 28, 2019 | news
MANALAPAN, N.J. and BASKING RIDGE, N.J., May 28, 2019 /PRNewswire/ — Armas Pharmaceuticals Inc. and Micro Labs USA, Inc. have announced today, the forming of a strategic collaboration to bring select multisource injectable products to the U.S. market. The first...
Recent Comments